Gallbladder Neoplasms Clinical Trial
Official title:
Chinese Research Group of Gallbladder Cancer
The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.
The objectives of the CRGGC are as follows: 1. To study the current diagnosis and treatment of gallbladder cancer in China. 2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer. 3. To improve the accurate staging of gallbladder cancer. 4. To standardize the treatment with gallbladder cancer. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05007106 -
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
|
Phase 2 | |
| Completed |
NCT01053390 -
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
|
Phase 3 | |
| Completed |
NCT03510923 -
Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy
|
||
| Recruiting |
NCT05786716 -
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06276153 -
Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer
|
||
| Completed |
NCT06178848 -
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
|
N/A | |
| Withdrawn |
NCT02174575 -
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
|
Phase 4 | |
| Completed |
NCT02430662 -
Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms
|
N/A | |
| Completed |
NCT01242605 -
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
|
Phase 1 |